{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:24:02Z","timestamp":1787833442971,"version":"build-2784847793"},"reference-count":38,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe, non-pitting edema, most commonly caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), resulting in excessive bradykinin production. HAE subtypes differ according to C1-INH levels, functional activity, underlying genetic variants, and increasingly recognized molecular mechanisms. Awareness of HAE outside specialized medical fields remains limited, and recurrent angioedema may arise through different pathophysiological mechanisms, which together contribute to frequent misdiagnosis, particularly in patients without a positive family history. Consequently, many patients experience significant diagnostic delays and inappropriate interventions. Rapid advances in endotype-based classification, molecular diagnostics, and targeted therapies have substantially changed the understanding and management of HAE, highlighting the need for an updated clinical overview. This review provides a comprehensive overview of HAE classification, clinical presentation, genetic background, diagnosis, and current management. Particular attention is given to advances in diagnostic biomarkers and genetic testing, newly approved targeted therapies, and oral on-demand treatment. Together, these advances are moving HAE management toward earlier diagnosis, more individualized treatment, and more patient-centered care.<\/jats:p>","DOI":"10.3390\/ijms27177680","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:03:43Z","timestamp":1787832223000},"page":"7680","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Swelling: Clinical Insights into the Diagnosis and Management of Hereditary Angioedema"],"prefix":"10.3390","volume":"27","author":[{"given":"Margarita","family":"Paulauskiene","sequence":"first","affiliation":[{"name":"Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania"},{"name":"Laboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tamasauskiene","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania"},{"name":"Laboratory of Immunology, Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5086-8893","authenticated-orcid":false,"given":"Brigita","family":"Gradauskiene","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergology, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50009 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12325-022-02401-0","article-title":"Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology","volume":"40","author":"Sinnathamby","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1159\/000543321","article-title":"Worldwide Prevalence of Hereditary Angioedema: A Systematic Review and Meta-Analysis","volume":"186","author":"Fisch","year":"2025","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2023.09.039","article-title":"Uncovering the true burden of hereditary angioedema due to C1-inhibitor deficiency: A focus on the Asia-Pacific region","volume":"153","author":"Honda","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","first-page":"e32075","article-title":"A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department","volume":"14","author":"Jayasinghe","year":"2022","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014The 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101335","DOI":"10.1016\/j.waojou.2026.101335","article-title":"The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities","volume":"19","author":"Josviack","year":"2026","journal-title":"World Allergy Organ. J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Santacroce, R., D\u2019Andrea, G., Maffione, A.B., Margaglione, M., and d\u2019Apolito, M. (2021). The Genetics of Hereditary Angioedema: A Review. JCM, 10.","DOI":"10.3390\/jcm10092023"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/rth2.12175","article-title":"Hereditary angioedema: Linking complement regulation to the coagulation system","volume":"3","author":"Levi","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Valerieva, A., and Longhurst, H.J. (2022). Treatment of hereditary angioedema\u2014Single or multiple pathways to the rescue. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.952233"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhou, N., Wu, J., and Zhi, Y. (2026). Endothelial barrier disorder in hereditary angioedema: Molecular mechanisms and therapeutic implications. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1853949"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2011.02.017","article-title":"Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation","volume":"128","author":"Bouillet","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","first-page":"82","article-title":"Pathophysiology and underlying mechanisms in hereditary angioedema","volume":"38","year":"2021","journal-title":"Balk. Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/joim.13182","article-title":"A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency","volume":"289","author":"Balla","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12135","DOI":"10.1002\/clt2.12135","article-title":"Comorbidities in hereditary angioedema\u2014A population-based cohort study","volume":"12","author":"Persson","year":"2022","journal-title":"Clin. Transl. Allergy"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Drouet, C., L\u00f3pez-Lera, A., Ghannam, A., L\u00f3pez-Trascasa, M., Cichon, S., Ponard, D., Parsopoulou, F., Grombirikova, H., Freiberger, T., and Rijavec, M. (2022). SERPING1 Variants and C1-INH Biological Function: A Close Relationship with C1-INH-HAE. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.835503"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1067\/mai.2000.110471","article-title":"Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema","volume":"106","author":"Pappalardo","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jaci.2012.11.015","article-title":"Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations","volume":"131","author":"Bors","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaci.2022.11.027","article-title":"Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses","volume":"151","author":"Ren","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12016-025-09027-4","article-title":"Hereditary Angioedema with Normal C1 Inhibitor: An Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment","volume":"68","author":"Zuraw","year":"2025","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101060","DOI":"10.1016\/j.waojou.2025.101060","article-title":"Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future","volume":"18","author":"Grumach","year":"2025","journal-title":"World Allergy Organ. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5152\/balkanmedj.2021.20060","article-title":"Angioedema without wheals: A clinical update","volume":"38","author":"Gulbahar","year":"2021","journal-title":"Balk. Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100511","DOI":"10.1016\/j.waojou.2021.100511","article-title":"Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema","volume":"14","author":"Ohsawa","year":"2021","journal-title":"World Allergy Organ. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/all.70207","article-title":"International Guideline on the Diagnosis and Management of Pediatric Patients with Hereditary Angioedema","volume":"81","author":"Farkas","year":"2026","journal-title":"Allergy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.transci.2003.08.007","article-title":"Sudden upper airway obstruction in patients with hereditary angioedema","volume":"29","author":"Bork","year":"2003","journal-title":"Transfus. Apher. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000479839","article-title":"An ABC of the Warning Signs of Hereditary Angioedema","volume":"174","author":"Grumach","year":"2017","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18176\/jiaci.0653","article-title":"Treatment of Hereditary Angioedema","volume":"31","author":"Caballero","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13023-023-02625-5","article-title":"C1-inhibitor\/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency","volume":"18","author":"Polai","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_28","first-page":"e40320","article-title":"Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report with a Review of Management Options","volume":"15","author":"Ameer","year":"2023","journal-title":"Cureus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2500\/aap.2015.36.3892","article-title":"Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey","volume":"36","author":"Longhurst","year":"2015","journal-title":"Allergy Asthma Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2010.04.012","article-title":"EDEMA4: A phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema","volume":"104","author":"Levy","year":"2010","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaip.2019.08.011","article-title":"Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema","volume":"8","author":"Valerieva","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.jaip.2021.04.072","article-title":"Lanadelumab Efficacy, Safety, and Injection Interval Extension in HAE: A Real-Life Study","volume":"9","author":"Buttgereit","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_33","first-page":"2","article-title":"Berotralstat: A data review of a novel oral medication for the treatment of hereditary angioedema","volume":"4","author":"Ohayon","year":"2024","journal-title":"Can. Allergy Immunol. Today"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(23)00350-1","article-title":"Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): A global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Craig","year":"2023","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2402478","article-title":"Efficacy and Safety of Donidalorsen for Hereditary Angioedema","volume":"391","author":"Riedl","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"AB426","DOI":"10.1016\/j.jaci.2025.12.948","article-title":"Significant HAE Attack Reduction with BW-20805, a Long-Acting Prophylactic Injection\u2014An Ongoing Phase 2 Study in Adult with Hereditary Angioedema","volume":"157","author":"Zhi","year":"2026","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cohn, D.M., Gurugama, P., Longhurst, H.J., Ayg\u00f6ren-P\u00fcrs\u00fcn, E., Craig, T.J., Farkas, H., Jacobs, J., Lumry, W.R., Magerl, M., and Peter, J. (2026). Lonvoguran Ziclumeran\u2014In Vivo CRISPR Gene Editing in Hereditary Angioedema. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2600931"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/JAA.S200900","article-title":"Self-Management Plans in Patients with Hereditary Angioedema: Strategies, Outcomes and Integration into Clinical Care","volume":"13","author":"Katelaris","year":"2020","journal-title":"J. Asthma Allergy"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7680\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:03:59Z","timestamp":1787832239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":38,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177680"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177680","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}